Zinkevych/iStock via Getty Images There is exciting news coming from Invitae’s (NYSE: NVTA) Q421 earnings call. The management team announced the intention to shift the focus from external capital-fueled growth to self-funding. To achieve that, the company will have to turn operating cash-flow positive. However, it will not be a one-year job. It will likely…
Eoneren/E+ via Getty Images Verve Therapeutics (NASDAQ:VERV) is a biotechnology company with a vision to provide cutting-edge solutions to cardiovascular diseases. Founded in 2018 with its headquarters in Cambridge, Massachusetts, the company’s reputable team of world-leading experts in human genetics aims to pioneer a new approach to treating cardiovascular disease with single-course gene-editing medicine. The…
Read More “Verve Therapeutics: Early-Stage Biotech With A Large Market” »
Funtay/iStock via Getty Images Looking at British American Tobacco (NYSE: BTI), it’s easy why some investors consider the company to be a risky proposition. Why would you want to invest in a product that many people say is on the way out, is unhealthy, and political risk? Well, that’s the thing with sin stocks –…
Read More “British American Tobacco (BTI): Still A 15%+ Upside With 6%+ Yield” »
Kevork Djansezian/Getty Images News Transaction Highlights Microsoft (NASDAQ:MSFT) will acquire Activision Blizzard (NASDAQ:ATVI) for $95.00 per share, in an all-cash transaction valued at $68.7 billion, inclusive of Activision Blizzard’s net cash. Merger Rationale Both Activision and Microsoft had incentives to go ahead with the deal. On the end of Activision, it has been plagued by…
Read More “Microsoft’s Activision Acquisition: Implications For FTC (MSFT) (ATVI)” »
By Ronni Stoeferle Intro by Matthew Piepenburg In the attached report, Matterhorn Asset Management advisor and Incrementum AG founder, Ronni Stoeferle, offers a compelling perspective on the rapid changes in the global monetary system and the massive implications behind Western sanctions unleashed on February 27th against Russia. As Ronni indicates, these measures…
PercyAlban/iStock Unreleased via Getty Images VictoryShares US Small Cap High Div Volatility Wtd ETF (NASDAQ:CSB) is a $201 million fund focusing on generous dividend payers from the small-cap echelon, with attention paid to the volatility factor to ensure there will be no frenetic price swings that dividend investors who typically pick stocks for the long…
Elon Musk has reportedly attempted to purchase Twitterand I have no idea whether his influence on the company would be positive or not. I do know, however, what other media figures think Musk’s influence on Twitter will be. They think it will be bad — very bad, bad! How none of them see what a…
Read More “Twitter’s Chickens Come Home to Roost – Investment Watch” »
Lemon_tm/iStock via Getty Images Written by Nick Ackerman, co-produced by Stanford Chemist. This article was originally published to members of the CEF/ETF Income Laboratory on April 14th, 2022. The Cushing NextGen Infrastructure Income Fund (NYSE: SZC) continues to catch my interest. The fund has been on what seems to be a perpetually deep discount since…
Read More “SZC: Deep Discount, Strong Coverage (NYSE:SZC)” »
The Q1 Earnings Season for the Gold Miners Index (GDX) is just around the corner, and one of the first companies to report its results is New Gold (NYSE: NGD). In line with the back-end weighted guidance, production was quite low in Q1 2022, down 8% year-over-year. However, production and costs are expected to improve…
Read More “New Gold: A Brighter Future For Rainy River (NYSE:NGD)” »
honglouwawa/iStock via Getty Images As expected, the US headline inflation rate for March was punchy (possibly a short-term peak for the annual rate, at least), although core moderated. I am currently focused on discussing the inflation experience of 2020-2021, and so I am not reading the entrails of the CPI report for predicting what is…
Read More “Central Banks Need To Focus On What They Can Control” »
